Status:
COMPLETED
Treatment of Hyperuricemia in Patients With Heart Failure
Lead Sponsor:
Tottori University Hospital
Conditions:
Heart Failure
Hyperuricemia
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
The study aims to assess (I) the contribution of UA itself to the CHF pathophysiology and (II) to test the effect of lowering UA by uricosuric treatment in CHF.
Detailed Description
Hyperuricemia is often observed in patients with congestive heart failure (CHF). It has been reported that hyperuricemia is related to exercise capacity, inflammation markers and diastolic dysfunction...
Eligibility Criteria
Inclusion
- chronic heart failure
- hyperuricemia
Exclusion
- renal dysfunction (Cr \> 2.0 mg/dl)
- under treatment with anti-diabetic agents
Key Trial Info
Start Date :
January 1 2004
Trial Type :
INTERVENTIONAL
End Date :
December 1 2005
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00422318
Start Date
January 1 2004
End Date
December 1 2005
Last Update
January 15 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tottori University Hospital
Yonago, Japan, 683-8504